http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112552376-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
filingDate 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112552376-B
titleOfInvention A kind of method of purifying vilacapide
abstract The invention discloses a purification method for solid-phase synthesis of veracatide, which belongs to the technical field of polypeptide medicine preparation. In this method, the solid-phase synthesized crude sample of veracatide is first dissolved in water; the crude peptide solution is added into an equal volume of acetonitrile solution and saturated sodium chloride solution to separate out, and the obtained solid is dissolved in water and then filtered, and a C18 reverse-phase chromatographic column is used to obtain 0.2% hydrochloric acid is phase A, acetonitrile is phase B, and a sample with a purity greater than 99.00% is obtained by gradient elution; the sample uses a C18 reverse-phase chromatographic column, with 50mmol/L ammonium chloride solution as phase A, acetonitrile as phase B, and the gradient is 5%‑5% to complete ion exchange, and then use 0.1% hydrochloric acid aqueous solution as phase A, acetonitrile as phase B, first gradient equilibrium, and then gradient elution to obtain the salted sample; the salted sample is concentrated under reduced pressure, freeze-dried to obtain vitamin Lacatide final product. The method of the invention greatly improves the processing capacity, shortens the production period, is suitable for industrialized large-scale production, improves the yield and reduces the production cost.
priorityDate 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428420340
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52212
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71511839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24694
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GL67
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XT35
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01269
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27IM2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04089

Total number of triples: 41.